1. AHRO : Austin Health Research Online

Belinda Yeo

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Belinda Yeo
Full Name
Yeo, Belinda
 
Department
 
ORCID
Loading... 3 0 20 0 false

Publications

Refined By:
Author:  Lok, Sheau Wen

Results 1-5 of 5 (Search time: 0.004 seconds).

Publication YearTitleAuthor(s)
1Feb-2023Addition of endocrine therapy to dual anti-HER2 targeted therapy in initial treatment of HER2 + /HR + metastatic breast cancer.Loft, Matthew; Lok, Sheau Wen; De Boer, Richard; Malik, Laeeq; Greenberg, Sally; Yeo, Belinda ; Anton, Angelyn; Nottage, Michelle; Wong, Vanessa ; Nott, Louise; Collins, Ian M; Torres, Javier; Barnett, Frances; Lombard, Janine M; Gibbs, Peter; Gately, Lucy
214-Jul-2022Real-World Outcomes in Patients With Brain Metastases Secondary to HER2-Positive Breast Cancer: An Australian Multi-centre Registry-based Study.Tung, Iris; Moldovan, Cristina; Wong, Vanessa ; De Boer, Richard; Yeo, Belinda ; Malik, Laeeq; Greenberg, Sally; Anton, Angelyn; Nott, Louise; Barnett, Frances; Collins, Ian M; Lombard, Janine; Nottage, Michelle; Sahu, Arvind; Torres, Javier; Gibbs, Peter; Lok, Sheau Wen
318-May-2021Uptake of bone modifying agents in patients with HER2+ metastatic breast cancer with bone metastases - prospective data from a multi-site Australian registry.Wong, Vanessa ; de Boer, Richard; Dunn, Catherine; Anton, Angelyn; Malik, Laeeq; Greenberg, Sally; Yeo, Belinda ; Nott, Louise; Collins, Ian M; Torres, Javier; Barnett, Frances; Nottage, Michelle; Gibbs, Peter; Lok, Sheau Wen
4Nov-2020Impact of prior (neo)adjuvant trastuzumab (NAT) exposure on the efficacy of HER2-targeted therapy for metastatic breast cancer.Kanjanapan, Yada; Lok, Sheau Wen; Gibbs, Peter; De Boer, Richard; Yeo, Belinda ; Greenberg, Sally; Barnett, Frances; Knott, Louise; Richardson, Gary; Wong, Rachel; Nottage, Michelle; Collins, Ian M; Torres, Javier; Lombard, Janine; Johns, Julie; Harold, Michael; Malik, Laeeq
55-Dec-2018A phase 1b dose-escalation and expansion study of the BCL-2 inhibitor venetoclax combined with tamoxifen in ER and BCL-2-positive metastatic breast cancer.Lindeman, Geoffrey J; Lok, Sheau Wen; Whittle, James R; Vaillant, Francois; Teh, Charis E; Lo, Louisa L; Policheni, Antonia N; Bergin, Alice R T; Desai, Jayesh; Ftouni, Sarah; Gandolfo, Luke C; Liew, Danny; Liu, He K; Mann, G Bruce; Moodie, Kate; Murugasu, Anand; Pal, Bhupinder; Roberts, Andrew W; Rosenthal, Mark A; Shackleton, Kylie; Silva, Maria J; Siow, Zhen R; Smyth, Gordon K; Taylor, Leanne; Travers, Avraham; Yeo, Belinda ; Yeung, Miriam M; Zivanovic Bujak, Andjelija; Dawson, Sarah-Jane; Gray, Daniel H D; Visvader, Jane E